vs
MERIT MEDICAL SYSTEMS INC（MMSI）与OLD NATIONAL BANCORP（ONB）财务数据对比。点击上方公司名可切换其他公司
OLD NATIONAL BANCORP的季度营收约是MERIT MEDICAL SYSTEMS INC的1.8倍（$702.8M vs $393.9M），OLD NATIONAL BANCORP净利率更高（33.3% vs 9.6%，领先23.6%），MERIT MEDICAL SYSTEMS INC同比增速更快（10.9% vs 0.6%），过去两年OLD NATIONAL BANCORP的营收复合增速更高（34.5% vs 10.3%）
梅里特医疗系统公司是一家全球性医疗设备企业，设计、生产和销售适用于心脏病学、放射学、肿瘤学、内窥镜及重症监护领域的介入和诊断产品，为全球医院及医疗机构提供微创医疗解决方案，助力提升患者疗效和临床操作效率。
Old National Bank是美国地区性银行，隶属于Old National Bancorp，总部位于芝加哥及印第安纳州埃文斯维尔，总资产485亿美元，拥有250个银行网点、近200家零售分行，是总部设于印第安纳州的最大金融服务银行控股公司，位列全美银行企业前30，业务覆盖美国八个州。
MMSI vs ONB — 直观对比
营收规模更大
ONB
是对方的1.8倍
$393.9M
营收增速更快
MMSI
高出10.3%
0.6%
净利率更高
ONB
高出23.6%
9.6%
两年增速更快
ONB
近两年复合增速
10.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $393.9M | $702.8M |
| 净利润 | $38.0M | $233.7M |
| 毛利率 | 49.6% | — |
| 营业利润率 | 13.8% | — |
| 净利率 | 9.6% | 33.3% |
| 营收同比 | 10.9% | 0.6% |
| 净利润同比 | 36.0% | 61.5% |
| 每股收益（稀释后） | $0.64 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MMSIONB
| Q1 26 | — | $702.8M | ||
| Q4 25 | $393.9M | $580.8M | ||
| Q3 25 | $384.2M | $574.6M | ||
| Q2 25 | $382.5M | $514.8M | ||
| Q1 25 | $355.4M | $387.6M | ||
| Q4 24 | $355.2M | $394.2M | ||
| Q3 24 | $339.8M | $391.7M | ||
| Q2 24 | $338.0M | $388.4M |
净利润MMSIONB
| Q1 26 | — | $233.7M | ||
| Q4 25 | $38.0M | $216.6M | ||
| Q3 25 | $27.8M | $182.6M | ||
| Q2 25 | $32.6M | $125.4M | ||
| Q1 25 | $30.1M | $144.7M | ||
| Q4 24 | $27.9M | $153.9M | ||
| Q3 24 | $28.4M | $143.8M | ||
| Q2 24 | $35.7M | $121.2M |
毛利率MMSIONB
| Q1 26 | — | — | ||
| Q4 25 | 49.6% | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.2% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | 48.7% | — | ||
| Q3 24 | 46.4% | — | ||
| Q2 24 | 47.7% | — |
营业利润率MMSIONB
| Q1 26 | — | — | ||
| Q4 25 | 13.8% | 46.7% | ||
| Q3 25 | 11.1% | 40.5% | ||
| Q2 25 | 12.3% | 30.2% | ||
| Q1 25 | 11.5% | 46.8% | ||
| Q4 24 | 10.3% | 47.2% | ||
| Q3 24 | 11.0% | 47.2% | ||
| Q2 24 | 13.6% | 40.3% |
净利率MMSIONB
| Q1 26 | — | 33.3% | ||
| Q4 25 | 9.6% | 37.3% | ||
| Q3 25 | 7.2% | 31.8% | ||
| Q2 25 | 8.5% | 24.4% | ||
| Q1 25 | 8.5% | 37.3% | ||
| Q4 24 | 7.9% | 39.0% | ||
| Q3 24 | 8.4% | 36.7% | ||
| Q2 24 | 10.6% | 31.2% |
每股收益（稀释后）MMSIONB
| Q1 26 | — | — | ||
| Q4 25 | $0.64 | $0.55 | ||
| Q3 25 | $0.46 | $0.46 | ||
| Q2 25 | $0.54 | $0.34 | ||
| Q1 25 | $0.49 | $0.44 | ||
| Q4 24 | $0.46 | $0.47 | ||
| Q3 24 | $0.48 | $0.44 | ||
| Q2 24 | $0.61 | $0.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $446.4M | — |
| 总债务越低越好 | $734.0M | — |
| 股东权益账面价值 | $1.6B | $8.5B |
| 总资产 | $2.7B | $73.0B |
| 负债/权益比越低杠杆越低 | 0.46× | — |
8季度趋势，按日历期对齐
现金及短期投资MMSIONB
| Q1 26 | — | — | ||
| Q4 25 | $446.4M | $1.8B | ||
| Q3 25 | $392.5M | $1.7B | ||
| Q2 25 | $341.8M | $1.8B | ||
| Q1 25 | $395.5M | $1.2B | ||
| Q4 24 | $376.7M | $1.2B | ||
| Q3 24 | $523.1M | $1.2B | ||
| Q2 24 | $636.7M | $1.2B |
总债务MMSIONB
| Q1 26 | — | — | ||
| Q4 25 | $734.0M | — | ||
| Q3 25 | $732.9M | — | ||
| Q2 25 | $731.8M | — | ||
| Q1 25 | $730.7M | — | ||
| Q4 24 | $729.6M | — | ||
| Q3 24 | $750.5M | — | ||
| Q2 24 | $801.3M | — |
股东权益MMSIONB
| Q1 26 | — | $8.5B | ||
| Q4 25 | $1.6B | $8.5B | ||
| Q3 25 | $1.5B | $8.3B | ||
| Q2 25 | $1.5B | $8.1B | ||
| Q1 25 | $1.4B | $6.5B | ||
| Q4 24 | $1.4B | $6.3B | ||
| Q3 24 | $1.3B | $6.4B | ||
| Q2 24 | $1.3B | $6.1B |
总资产MMSIONB
| Q1 26 | — | $73.0B | ||
| Q4 25 | $2.7B | $72.2B | ||
| Q3 25 | $2.6B | $71.2B | ||
| Q2 25 | $2.6B | $71.0B | ||
| Q1 25 | $2.5B | $53.9B | ||
| Q4 24 | $2.4B | $53.6B | ||
| Q3 24 | $2.4B | $53.6B | ||
| Q2 24 | $2.4B | $53.1B |
负债/权益比MMSIONB
| Q1 26 | — | — | ||
| Q4 25 | 0.46× | — | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 0.49× | — | ||
| Q1 25 | 0.51× | — | ||
| Q4 24 | 0.53× | — | ||
| Q3 24 | 0.57× | — | ||
| Q2 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $98.5M | — |
| 自由现金流经营现金流 - 资本支出 | $74.0M | — |
| 自由现金流率自由现金流/营收 | 18.8% | — |
| 资本支出强度资本支出/营收 | 6.2% | — |
| 现金转化率经营现金流/净利润 | 2.59× | — |
| 过去12个月自由现金流最近4个季度 | $215.7M | — |
8季度趋势，按日历期对齐
经营现金流MMSIONB
| Q1 26 | — | — | ||
| Q4 25 | $98.5M | $159.2M | ||
| Q3 25 | $75.0M | $341.2M | ||
| Q2 25 | $83.3M | $72.9M | ||
| Q1 25 | $40.6M | $108.2M | ||
| Q4 24 | $68.7M | $235.8M | ||
| Q3 24 | $47.3M | $121.3M | ||
| Q2 24 | $68.5M | $161.0M |
自由现金流MMSIONB
| Q1 26 | — | — | ||
| Q4 25 | $74.0M | $137.3M | ||
| Q3 25 | $52.5M | $333.6M | ||
| Q2 25 | $69.6M | $64.1M | ||
| Q1 25 | $19.5M | $102.4M | ||
| Q4 24 | $65.3M | $229.0M | ||
| Q3 24 | $38.0M | $115.7M | ||
| Q2 24 | $57.9M | $151.6M |
自由现金流率MMSIONB
| Q1 26 | — | — | ||
| Q4 25 | 18.8% | 23.6% | ||
| Q3 25 | 13.7% | 58.1% | ||
| Q2 25 | 18.2% | 12.4% | ||
| Q1 25 | 5.5% | 26.4% | ||
| Q4 24 | 18.4% | 58.1% | ||
| Q3 24 | 11.2% | 29.5% | ||
| Q2 24 | 17.1% | 39.0% |
资本支出强度MMSIONB
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | 3.8% | ||
| Q3 25 | 5.8% | 1.3% | ||
| Q2 25 | 3.6% | 1.7% | ||
| Q1 25 | 5.9% | 1.5% | ||
| Q4 24 | 1.0% | 1.7% | ||
| Q3 24 | 2.8% | 1.4% | ||
| Q2 24 | 3.1% | 2.4% |
现金转化率MMSIONB
| Q1 26 | — | — | ||
| Q4 25 | 2.59× | 0.73× | ||
| Q3 25 | 2.70× | 1.87× | ||
| Q2 25 | 2.56× | 0.58× | ||
| Q1 25 | 1.35× | 0.75× | ||
| Q4 24 | 2.46× | 1.53× | ||
| Q3 24 | 1.66× | 0.84× | ||
| Q2 24 | 1.92× | 1.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MMSI
| Other | $154.6M | 39% |
| Peripheral Intervention | $93.2M | 24% |
| Cardiac Intervention | $50.2M | 13% |
| OEM | $42.6M | 11% |
| Custom Procedural Solutions | $33.1M | 8% |
| Endoscopy Segment | $20.1M | 5% |
ONB
暂无分部数据
